Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation.
about
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORThe Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy AgingErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyAt the interface of antioxidant signalling and cellular function: Key polyphenol effectsResearch Progress on Signaling Pathway-Associated Oxidative Stress in Endothelial Cells.Quercetin delays postovulatory aging of mouse oocytes by regulating SIRT expression and MPF activity.Redox homeostasis, T cells and kidney diseases: three faces in the dark.Baicalein protects against oxLDL-caused oxidative stress and inflammation by modulation of AMPK-alphaToxicity assessment of hydrogen peroxide on Toll-like receptor system, apoptosis, and mitochondrial respiration in piglets and IPEC-J2 cells.Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.Quercetin protects against atherosclerosis by inhibiting dendritic cell activation.Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells.SIRT1 inhibition promotes atherosclerosis through impaired autophagy.Regulation of Sirtuin-Mediated Protein Deacetylation by Cardioprotective Phytochemicals.Salidroside, A Natural Antioxidant, Improves β-Cell Survival and Function via Activating AMPK Pathway.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure
P2860
Q26749047-90D953BC-798E-46FF-94CE-1BFE1911FAA5Q26771190-F2CB9DD9-4CF9-4316-BFBC-61929BB22C6AQ28066377-8C037AB3-3B0D-4BB1-BF44-98019BF76D1FQ28071627-5D1184DF-EEE3-40D6-8431-C87C0FE6C6C9Q33631220-E61E4945-0709-4D5D-9330-CB36865BA932Q33888901-2A3FF629-D3A2-4626-A91D-860425D7E2F2Q36482958-FDF8AA48-D093-4098-BA66-3E4796A8510AQ37687237-7DC04DAA-28A6-4801-95D8-E0F291034570Q37709433-BA9FCFFF-5809-4196-8EA4-8331FB5E3469Q38655453-2543893E-A6D3-4C08-8F81-59971480F461Q38665115-32FFF571-7260-4979-AC00-8E3E816B2F9BQ38789540-4C355F26-5EE5-49C5-AE36-CE6A88D99A37Q38812509-1927DCA7-0840-4254-8B17-6206FC5D63E4Q39331686-A2FC1BD5-0B27-4B4B-BB19-00D7BEEDB239Q41612831-F4533460-411B-4F8A-8285-E90B9767F57FQ45827486-6D7D711C-4C30-4074-8342-DD4DA544EC44Q46270513-C5DEDB9A-1BFE-4016-ADF3-08A13ACE748EQ51761339-E0D86C9B-DF64-46BD-A251-B64509210CBCQ52361076-9328A63A-567F-4920-8664-0A0D465EDD34Q58766782-ACA07B3C-E174-4881-B941-89C906DDB7F8
P2860
Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@ast
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@en
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@nl
type
label
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@ast
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@en
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@nl
prefLabel
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@ast
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@en
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@nl
P2093
P2860
P356
P1476
Quercetin is a potent anti-ath ...... aling under oxLDL stimulation.
@en
P2093
Ching-Hsia Hung
Kun-Ling Tsai
Pei-Ming Chu
Shih-Hung Chan
P2860
P304
P356
10.1002/MNFR.201500144
P577
2015-07-23T00:00:00Z